Dosage Forms

Reshaping Dosage Forms

Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Frontrunners in Bispecific Antibodies

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Alexion to Build Biologics Facility in Ireland

May 19, 2015

Alexion will construct a biologics facility in Ireland that is its first outside the US.

Sterilization Effects on Elastomers in Sterile Parenteral Drug Products

May 15, 2015

This article looks at data gathered from several studies of a widely marketed chlorobutyl rubber formulation used for vial stoppers and prefilled syringes.

Controlled Nucleation for a Monoclonal Antibody Formulation—A Case Study

May 15, 2015

This study evaluates the impact of controlled nucleation on the ability to optimize a lyophilization cycle for a monoclonal antibody formulation.

Pall to be Acquired by Danaher

May 13, 2015

Pall has agreed to be acquired by Danaher for $127.20 per share.

Baxter BioScience Expands Oncology Business

May 13, 2015

With acquisition of Oncaspar portfolio for leukemia from Sigma-Tau Finanziaria, Baxter BioScience adds an oncology infrastructure and biologic.

Meggle Introduces New High-Functionality Excipient

May 12, 2015

CombiLac is a lactose-based, co-processed excipient, designed to ease oral solid dosage form development and manufacture in direct compression.

FDA Releases Q&A on Biosimilars

May 12, 2015

The agency publishes draft guidance answering industry questions about the Biologics Price Competition and Innovation Act.

Vaccine Patch Could Eliminate Traditional Protocol for Vaccine Delivery

May 11, 2015

A vaccine patch may eliminate the need for traditional means of vaccine distribution, according to an article in NPR.

Court Blocks First FDA-Approved Biosimilar, for the Time Being

May 07, 2015

The US Court of Appeals granted Amgen’s request to block Novartis’ Neupogen biosimilar, Zarxio, from the US market until the court resolves litigation between the two companies.

Biosimilar Giants Launch Biosimilars Forum

May 06, 2015

Eleven of the leading US biosimilar developers have collaborated to form the Biosimilars Forum, a nonprofit organization formed to expand patient access to biosimilars.